Скачать или смотреть Ep 9. Attorney and healthcare regulatory insider Matt Wetzel joins the podcast

#healthcare #regulation #NIH #Medicaid #FDA #JPMorganhealthcareconference #medicaltechnology #lifesciences #healthcarepolicy

In this episode of Value Health Voices, hosts Anthony Paravati and Amar Rewari welcome Matt Wetzel, a trustee at the American Health Law Institute, to discuss the complex regulatory environment surrounding healthcare. The conversation covers insights from the JPMorgan Healthcare Conference, changes in NIH grant funding, Medicaid spending, and the future of FDA regulations. Wetzel emphasizes the importance of understanding the nuances of healthcare policy and encourages listeners to look beyond sensational headlines to grasp the underlying issues affecting the industry.

Summary
Matt Wetzel is a lawyer specializing in medical technology and life sciences.
The JPMorgan Healthcare Conference is a key networking event in the industry.
The Trump administration is focused on efficiency in healthcare regulation.
NIH has implemented a cap on indirect costs for grants.
There is a debate within the industry about the appropriateness of indirect cost caps.
Medicaid spending is a politically sensitive issue that may face cuts.
The FDA's regulatory environment is evolving, with potential for increased efficiency.
Personnel changes in government can significantly impact healthcare policy.
The media often sensationalizes healthcare regulatory changes.
Understanding the details of regulations is crucial for stakeholders.

Chapters

00:00 Introduction to the Regulatory Landscape
04:53 Insights from the JPMorgan Healthcare Conference
10:16 Changes in NIH Grant Funding
20:33 Medicaid Spending and Work Requirements
24:03 Understanding Federal Health Programs
28:24 Navigating Regulatory Challenges
32:47 The Strategic Landscape of Healthcare Policy
38:23 The Future of Leadership in Healthcare
42:59 Key Takeaways for Navigating Change